TransDigm (TDG) PT Raised to $475 at UBS
Tweet
Share
E-mail
Get Alerts TDG Hot Sheet
Price: $1,146.44 -1.34%
Rating Summary:
18 Buy, 16 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Rating Summary:
18 Buy, 16 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 25 | Down: 24 | New: 33
Join SI Premium – FREE
UBS raised its price target on TransDigm (NYSE: TDG) to $475.00 (from $415.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Pharvaris B.V. (PHVS) PT Raised to $75 at Oppenheimer
- Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
